A randomized trial to assess effectiveness and cost in clinical practice: Rationale and design of the cholesterol reduction intervention study (CRIS)
- 28 February 1995
- journal article
- research article
- Published by Elsevier BV in Controlled Clinical Trials
- Vol. 16 (1), 3-16
- https://doi.org/10.1016/0197-2456(94)00028-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Niacin revisited: Clinical observations on an important but underutilized drugAmerican Journal Of Medicine, 1991
- Expanded Clinical Evaluation of Lovastatin (EXCEL) Study ResultsArchives of Internal Medicine, 1991
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- The MOS Short-form General Health SurveyMedical Care, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsArchives of Internal Medicine, 1988
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJournal of the American College of Cardiology, 1986
- Therapeutic Response to Lovastatin (Mevinolin) in Nonfamilial HypercholesterolemiaJama-Journal Of The American Medical Association, 1986
- Concurrent and Predictive Validity of a Self-reported Measure of Medication AdherenceMedical Care, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJama-Journal Of The American Medical Association, 1984
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975